Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.
Díaz-Beyá M, Labopin M, Maertens J, Aljurf M, Passweg J, Dietrich B, Schouten H, Socié G, Schaap N, Schwerdtfeger R, Volin L, Michallet M, Polge E, Sierra J, Mohty M, Esteve J, Nagler A; Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Br J Haematol. 2020 Jun;189(5):920-925. doi: 10.1111/bjh.16433. Epub 2020 Feb 5.
Acute Myeloid Leukemia with t(6;9)(p23;q34.1); DEK-NUP214: The Pathogenesis and Potential.
Gardner JA, Donnelly L, Goetz R, Waller B, Devitt K.
J Assoc Genet Technol. 2020;46(2):98-102.
Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy.
Day JW, Fox TA, Gupta R, Khwaja A, Wilson AJ, Kottaridis PD.
Leuk Res Rep. 2022 Feb 7;17:100291. doi: 10.1016/j.lrr.2022.100291. eCollection 2022.
t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities.
Baldazzi C, Luatti S, Marzocchi G, Grassi A, Cavo M, Testoni N.
Cancer Genet. 2022 Apr;262-263:35-39. doi: 10.1016/j.cancergen.2021.12.006. Epub 2021 Dec 22.
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).
Andreozzi F, Galimard JE, Maertens J, Aljurf M, Clesham K, Sanz J, Maury S, Loron S, Passweg J, Schroeder T, Salmenniemi U, van Gorkom G, Peffault de Latour R, von dem Borne PA, Locatelli F, Wynn RF, Dalle JH, Esteve J, Nagler A, Kleinschmidt K, Mohty M, Kalwak K, Ciceri F.
Bone Marrow Transplant. 2026 Apr 22. doi: 10.1038/s41409-026-02857-6. Online ahead of print.
Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34).
Visconte V, Shetty S, Przychodzen B, Hirsch C, Bodo J, Maciejewski JP, Hsi ED, Rogers HJ.
Int J Lab Hematol. 2017 Aug;39(4):409-417. doi: 10.1111/ijlh.12641. Epub 2017 Mar 20.
A novel variant translocation (1;9)(p22;q34) resulting in a DEK/NUP214 fusion gene in a patient with acute myeloid leukemia: A case report.
Hao Q, Zhang Q, Li C, Wei S, Li Q, Song Y, Mi Y.
Oncol Lett. 2017 Dec;14(6):7021-7024. doi: 10.3892/ol.2017.7133. Epub 2017 Oct 3.
[Classification of myeloid leukemias].
Kuriyama K.
Nihon Rinsho. 2009 Oct;67(10):1853-62.
